Deloitte University Press
3D opportunity for health care
While additive manufacturing (AM) has the potential to radically change health care, enabling greater customization and design innovation, many companies hesitate to use AM due to the complexity of FDA regulations. Learn how your AM strategy can inform your path to regulatory approval.
Social determinants and collaborative health care: Improved outcomes, reduced costs
Implications and opportunities for health plans and states
This whitepaper explains some of the impacts that physical health, behavioral health, and social determinants have on individuals and the US health system.
Measuring the return from pharmaceutical innovation 2014
Turning a corner?
The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.